Some cases of hypermobile Ehlers–Danlos syndrome may be rooted in mast cell activation syndrome
- 31 October 2021
- journal article
- review article
- Published by Wiley in American Journal of Medical Genetics Part C: Seminars in Medical Genetics
- Vol. 187 (4) , 466-472
Abstract
Hypermobile Ehlers–Danlos syndrome (hEDS) is the most common type of EDS, yet has remained steadfastly inscrutable vis‐à‐vis efforts to identify its cellular, molecular, and pathophysiologic roots. Once thought to principally affect just connective tissues, hEDS is now appreciated to be a multisystem disease of great heterogeneity with many symptoms and findings difficult to attribute solely to disordered connective tissue development. In the last decade, there has been growth in the appreciation of the existence of a wide range of disorders of chronic inappropriate mast cell (MC) activation (a large heterogeneous pool of MC activation syndromes [MCAS]) distinguishable from other MC disorders such as rare neoplastic mastocytosis. Via chronic aberrant release of the MC's vast repertoire of potent mediators, MCAS can drive extraordinary arrays of pathologies, most commonly of inflammatory, allergic, and dystrophic natures. Although hEDS is seen in only a minority of MCAS cases, limited studies have identified an association between hEDS and MCAS, fueling speculation that certain variants of MCAS may drive hEDS. No laboratory studies probing cellular or molecular linkages between hEDS and MCAS have been conducted yet, and research efforts to identify the genetic roots of hEDS should also consider those of MCAS.Keywords
This publication has 52 references indexed in Scilit:
- Familial Occurrence of Systemic Mast Cell Activation DiseasePLOS ONE, 2013
- Clinical heterogeneity in patients with the hypermobility type of Ehlers-Danlos SyndromeResearch in Developmental Disabilities, 2013
- Ehlers-Danlos Syndrome, Hypermobility Type: An Underdiagnosed Hereditary Connective Tissue Disorder with Mucocutaneous, Articular, and Systemic ManifestationsISRN Dermatology, 2012
- Management of pain and fatigue in the joint hypermobility syndrome (a.k.a. Ehlers–Danlos syndrome, hypermobility type): Principles and proposal for a multidisciplinary approachAmerican Journal of Medical Genetics Part A, 2012
- An exploration of the prevalence of hypermobility and joint hypermobility syndrome in Omani women attending a hospital physiotherapy serviceMusculoskeletal Care, 2011
- Ehlers–Danlos syndrome hypermobility type and the excess of affected females: Possible mechanisms and perspectivesAmerican Journal of Medical Genetics Part A, 2010
- The lack of clinical distinction between the hypermobility type of Ehlers–Danlos syndrome and the joint hypermobility syndrome (a.k.a. hypermobility syndrome)American Journal of Medical Genetics Part A, 2009
- Ehlers‐Danlos syndrome – a historical reviewBritish Journal of Haematology, 2008
- Multiple novel alterations inKittyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorderScandinavian Journal of Gastroenterology, 2007
- Joint hypermobility and skin elasticity: the hereditary disorders of connective tissueClinics in Dermatology, 2006